3 FTSE shares with big dividends I’d like to buy right now

I think these three FTSE shares could be some of the best dividend investments on the London stock market and I’d buy them in these uncertain times.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A person holding onto a fan of twenty pound notes

Image source: Getty Images.

One strategy for constructing a long-term portfolio of shares involves focusing on the shareholder dividends companies pay. If I collect a large yield in income and plough the proceeds back into my shares, I’ll be compounding my investments.

Another benefit of focusing on the shareholder dividend is that big yields often indicate a modest valuation. So, if the annual dividend grows over time, there’s a good chance the share price will also rise and deliver capital growth in my portfolio as well.

5 Stocks For Trying To Build Wealth After 50

One notable billionaire made 99% of his current wealth after his 50th birthday. And here at The Motley Fool, we believe it is NEVER too late to start trying to build your fortune in the stock market. Our expert Motley Fool analyst team have shortlisted 5 companies that they believe could be a great fit for investors aged 50+ trying to build long-term, diversified portfolios.

Click here to claim your free copy now!

However, the strategy works best if I target sustainable dividends. So, I’ll avoid cyclical businesses and look for firms with strong finances operating in a profitable niche of the market, such as these three.

Pharmaceuticals

The recent bout of general stock market weakness has pushed down the share price of pharmaceuticals giant GlaxoSmithKline (LSE: GSK). It seems the company is out of favour with investors. One reason for that could be a general rotation out of defensive companies and into cyclical stocks that look poised for the next cyclical up-leg.

Indeed, although the likes of GlaxoSmithKline do operate cash-producing, defensive businesses, their valuations can move up and down in cycles. And right now, I think the valuation has cycled down.

And at the current share price near 1,350p, the dividend yield is just below 6%. Meanwhile, nobody expects much growth in earnings in the near term. But I do reckon the firm can keep up its dividend payments. For me, GlaxoSmithKline would make a decent long-term hold in my portfolio.

Power transmission

National Grid (LSE: NG), has a forward-looking dividend yield of just over 5% for the current trading year to March 2021. The guardian of the nation’s gas and electricity transmission networks has been a steady dividend payer for many years. And it’s clear the firm’s highly regulated monopoly position in the UK’s energy sector endows the business with defensive qualities.

The company also has operations in the US. And although National Grid carries a big debt load, the rock-solid cash generation it achieves makes sense of the high level of borrowings. However, the business requires large and continuous amounts of capital investment. And the directors must balance the cash flow returns to the company’s lenders and to its shareholders.

I don’t expect the business to ever shoot the lights out with growth. But I do think it’s capable of churning out those generous shareholder dividends for years to come.

Food additives

The food sector has defensive qualities and Tate & Lyle (LSE: TATE) is a big player in it. The company produces ingredients and solutions to the food, beverage and other industries, and it’s a lucrative market. We can see by the firm’s long record of paying generally rising shareholder dividends how well the cash keeps rolling in.

The share price has slipped back a bit this autumn and now stands near 612p. At that level, the forward-looking dividend yield for the current trading year to March 2021 is a little below 5%. Meanwhile, the company has already shown its resilience by trading well through the recent coronavirus lockdowns.

So, I’d treat a holding in the firm’s shares now as a sleep-at-night investment. And I’d hold with the tenacity of a business owner for at least the next 20 years.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A Rolls-Royce employee works on an engine
Investing Articles

In penny stock territory, is the Rolls-Royce share price set to soar?

The Rolls-Royce share price has sunk recently, falling into penny stock territory. But with flying hours recovering, is it too…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Lloyds shares drop 20% in 4 months. Should I buy now?

Lloyds shares have lost a fifth of their value since peaking on 17 January this year. But after rebounding from…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

As the stock market recovery stalls, should I wait to buy?

Has the stock market recovery run out of steam? If so, what does that mean for our writer's portfolio? Here…

Read more »

Diagonal chain made of zeros and ones. Cryptocurrency and mining.
Investing Articles

At 55p, is the Argo Blockchain (LON:ARB) share price too cheap to miss?

With a low P/E ratio and strong financial results, could the Bitcoin miner be good value for money?

Read more »

macro shot of computer monitor with FTSE 100 stock market data in trading application
Investing Articles

Here are 2 recession-proof FTSE stocks!

In the face of current economic uncertainty and fears of a looming recession, this Fool identifies two recession-proof FTSE stocks.

Read more »

British Pennies on a Pound Note
Investing Articles

Here is 1 penny stock primed to benefit from the construction boom!

Jabran Khan delves deeper into a penny stock that he believes could benefit from the construction boom, and explains why…

Read more »

Various denominations of notes in a pile
Investing Articles

Here is 1 top passive income stock to buy and hold!

Jabran Khan wants to boost his passive income stream through dividends and has identified this insurance giant as a way…

Read more »

Cheerful young businesspeople with laptop working in office
Investing Articles

These are the 5 worst ways to invest in stocks

It's all too easy to lose money when you don't really know how to invest in stocks. Here are the…

Read more »